The fluorometric microculture cytotoxicity assay
- 31 July 2008
- journal article
- Published by Springer Science and Business Media LLC in Nature Protocols
- Vol. 3 (8), 1364-1369
- https://doi.org/10.1038/nprot.2008.114
Abstract
The fluorometric microculture cytotoxicity assay (FMCA) is a nonclonogenic microplate-based cell viability assay used for measurement of the cytotoxic and/or cytostatic effect of different compounds in vitro. The assay is based on hydrolysis of the probe, fluorescein diacetate (FDA) by esterases in cells with intact plasma membranes. The assay is available as both a semiautomated 96-well plate setup and a 384-well plate version fully adaptable to robotics. Experimental plates are prepared with a small amount of drug solution and can be stored frozen. Cells are seeded on the plates and cell viability is evaluated after 72 h. The protocol described here is applicable both for cell lines and freshly prepared tumor cells from patients and is suitable both for screening in drug development and as a basis for a predictive test for individualization of anticancer drug therapy.Keywords
This publication has 10 references indexed in Scilit:
- The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitroInvestigational New Drugs, 2007
- Primary lymphocytes as predictors for species differences in cytotoxic drug sensitivityToxicology in Vitro, 2007
- Pharmacological profiling of novel non-COX-inhibiting indole-pyran analogues of etodolac reveals high solid tumour activity of SDX-308 in vitroInvestigational New Drugs, 2007
- R-etodolac (SDX-101) and the related indole–pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cellsCancer Chemotherapy and Pharmacology, 2006
- Phenotype-Based Screening of Mechanistically Annotated Compounds in Combination with Gene Expression and Pathway Analysis Identifies Candidate Drug Targets in a Human Squamous Carcinoma Cell ModelSLAS Discovery, 2006
- Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinicEuropean Journal of Cancer, 1999
- Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistanceBritish Journal of Cancer, 1996
- Cytotoxic Drug Sensitivity Testing of Tumor Cells from Patients with Ovarian Carcinoma Using the Fluorometric Microculture Cytotoxicity Assay (FMCA)Gynecologic Oncology, 1994
- Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)International Journal of Cancer, 1992
- Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell LinesJNCI Journal of the National Cancer Institute, 1990